New Ray Medicine International Holding Ltd. logo

New Ray Medicine International Holding Ltd.

6108.HK

HKSEHealthcareMedical - Pharmaceuticals

最新数据

HK$0.225

+HK$0.016 · +7.66%

8月21日 13:10 HKT延迟

6108.HK公司概览

盘中时间采用HKT。市场数据可能有所延迟。

公司概况

公司网站

New Ray Medicine International Holding Ltd. is an investment company, which engages in the distribution and trading of pharmaceutical products. It operates through the following business segments: Injection Drugs; Capsule and Granule Drugs; Tablet Drugs; Marketing and Promotion Services; and Others. The Injection Drugs segment includes the trading of injection drugs. The Capsule and Granule Drugs segment relates to the selling of capsule and granule drugs. The Tablet Drugs segment comprises tablet drugs. The Marketing and Promotion Services segment focuses in the marketing and promotion of services of drugs. The Others segment trades miscellaneous types of goods and drugs, other than injection drugs, capsule and granule drugs, and tablet drugs. The company was founded on August 9, 2012 and is headquartered in Hangzhou, China.

行业
Medical - Pharmaceuticals
部门
Healthcare
总部
CN
首席执行官
Qiuqin Wang
上市以来
2013年10月28日
雇员
31

市场位置

52周区间

当前HK$0.225,

开盘价
HK$0.225
前收盘价
HK$0.209
成交量
7.2万
0.79× 平均值
平均成交量
9.13万
日均成交量
市值
4513.88万 HKD
贝塔
-3.94
市场参考 1
50天平均值
HK$0.2061
高于平均水平+9.15%
200天平均值
HK$0.2284
低于平均水平-1.49%

6108.HK同业公司

继续GoAI的研究

在 GoAI 中研究6108.HK

research.disclaimer